orforglipron semaglutide FDA Approval: Why the First Small-Molecule GLP-1 Pill Matters Oral Semaglutide Demonstrates Greater Weight
Description
Semaglutides role in managing blood sugar and insulin levels and promoting weight loss is significant
The term for this patent is expected to expire in 2031, subject to potential patent term extensions (PTE)
For patients exploring weight management with diabetes medications considering gastric sleeve, gastric bypass, duodenal switch or SADI surgery
Zhang L, He J, Sun X, et al
A study by Ullum et al
Combining medication with lifestyle changes often yields the best results
